OR8G5
gene geneOn this page
Summary
OR8G5 (olfactory receptor family 8 subfamily G member 5, HGNC:19622) is a protein-coding gene on chromosome 11q24.2, encoding Olfactory receptor 8G5 (Q8NG78). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 219865 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 52 total — 1 pathogenic
- MANE Select transcript:
NM_001005198
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19622 |
| Approved symbol | OR8G5 |
| Name | olfactory receptor family 8 subfamily G member 5 |
| Location | 11q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000255298 |
| Ensembl biotype | protein_coding |
| Entrez | 219865 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000641707, ENST00000641992
RefSeq mRNA: 1 — MANE Select: NM_001005198
NM_001005198
CCDS: CCDS66256
Canonical transcript exons
ENST00000641992 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003811991 | 124264918 | 124266224 |
| ENSE00003812384 | 124256376 | 124256634 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 86.72.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0265 / max 16.2905, expressed in 6 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 117359 | 0.0265 | 6 |
Top tissues by expression
113 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.72 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.19 | gold quality |
| left testis | UBERON:0004533 | 56.81 | gold quality |
| testis | UBERON:0000473 | 56.60 | gold quality |
| right testis | UBERON:0004534 | 53.83 | gold quality |
| placenta | UBERON:0001987 | 48.21 | gold quality |
| bone marrow cell | CL:0002092 | 38.70 | gold quality |
| duodenum | UBERON:0002114 | 37.92 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| sural nerve | UBERON:0015488 | 36.80 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.66 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| mucosa of stomach | UBERON:0001199 | 35.97 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.38 | gold quality |
| bone marrow | UBERON:0002371 | 34.24 | gold quality |
| muscle tissue | UBERON:0002385 | 33.81 | gold quality |
| transverse colon | UBERON:0001157 | 33.18 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| rectum | UBERON:0001052 | 31.17 | gold quality |
| urinary bladder | UBERON:0001255 | 31.03 | silver quality |
| lower esophagus muscularis layer | UBERON:0035833 | 30.43 | gold quality |
| lower esophagus | UBERON:0013473 | 30.38 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 30.02 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| vermiform appendix | UBERON:0001154 | 29.66 | gold quality |
| lung | UBERON:0002048 | 29.56 | gold quality |
| monocyte | CL:0000576 | 29.50 | gold quality |
| leukocyte | CL:0000738 | 29.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.79 |
Regulation
Is transcription factor: no
Cross-species orthologs
27 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or8g19 | ENSMUSG00000049708 |
| mus_musculus | Or8g30 | ENSMUSG00000057349 |
| mus_musculus | Or8g17 | ENSMUSG00000058820 |
| mus_musculus | Or8g21 | ENSMUSG00000059595 |
| mus_musculus | Or8g20 | ENSMUSG00000062649 |
| mus_musculus | Or8g28 | ENSMUSG00000063380 |
| mus_musculus | Or8g23 | ENSMUSG00000094182 |
| mus_musculus | Or8g32 | ENSMUSG00000094269 |
| mus_musculus | Or8g34 | ENSMUSG00000094745 |
| mus_musculus | Or8g26 | ENSMUSG00000094970 |
| mus_musculus | Or8g18 | ENSMUSG00000096109 |
| mus_musculus | Or8g27 | ENSMUSG00000096555 |
| rattus_norvegicus | ENSRNOG00000069156 | |
| rattus_norvegicus | Or8g18c | ENSRNOG00000069965 |
| rattus_norvegicus | Or8g21 | ENSRNOG00000070533 |
| rattus_norvegicus | Or8g30 | ENSRNOG00000073447 |
| rattus_norvegicus | Or8g20e | ENSRNOG00000075099 |
| rattus_norvegicus | Or8g34 | ENSRNOG00000075420 |
| rattus_norvegicus | Or8g34b | ENSRNOG00000075547 |
| rattus_norvegicus | Or8g26c | ENSRNOG00000076721 |
| rattus_norvegicus | Or8g26 | ENSRNOG00000079933 |
| rattus_norvegicus | Or8g28 | ENSRNOG00000082314 |
| rattus_norvegicus | Or8g23 | ENSRNOG00000082549 |
| rattus_norvegicus | Or8g17d | ENSRNOG00000082629 |
| rattus_norvegicus | Or8g20b | ENSRNOG00000082989 |
| rattus_norvegicus | Or8g20 | ENSRNOG00000088588 |
| rattus_norvegicus | Or8g18e | ENSRNOG00000090255 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761)
Protein
Protein identifiers
Olfactory receptor 8G5 — Q8NG78 (reviewed: Q8NG78)
Alternative names: Olfactory receptor 8G6, Olfactory receptor OR11-298
All UniProt accessions (1): A0A126GW95
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005198* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, glycosylation site 2, chain 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NG78-F1 | 83.27 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 132–214
Glycosylation sites (2): 16, 40
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, chr11q24, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS
GO Biological Process (4): G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), signal transduction (GO:0007165), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
190 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR8G5 | SLC24A3 | Q9HC58 | 514 |
| OR8G5 | PLBD2 | Q8NHP8 | 470 |
| OR8G5 | GPAA1 | O43292 | 378 |
| OR8G5 | H0YL38 | H0YL38 | 369 |
| OR8G5 | ZNF280D | Q6N043 | 365 |
| OR8G5 | CRYBG2 | Q8N1P7 | 360 |
| OR8G5 | GAS2L2 | Q8NHY3 | 359 |
| OR8G5 | ALPG | P10696 | 350 |
| OR8G5 | KIAA1755 | Q5JYT7 | 349 |
| OR8G5 | YBX2 | Q9Y2T7 | 348 |
| OR8G5 | QRICH2 | Q9H0J4 | 348 |
| OR8G5 | LDHAL6B | Q9BYZ2 | 332 |
| OR8G5 | TMEM87A | Q8NBN3 | 325 |
| OR8G5 | SCUBE2 | Q9NQ36 | 323 |
| OR8G5 | TYW1 | Q9NV66 | 323 |
IntAct
0 interactions, top by confidence:
BioGRID (1): OR8G5 (Protein-RNA)
ESM2 similar proteins: A6ND48, A6NFC9, B2RN74, O43869, O60412, O60431, P23265, P31388, P34987, P47883, P47884, P47887, P58170, Q0VAX9, Q5JRS4, Q60894, Q6IFN5, Q7Z3T1, Q8NG78, Q8NG84, Q8NG94, Q8NG99, Q8NGC0, Q8NGC1, Q8NGC5, Q8NGE7, Q8NGG2, Q8NGG3, Q8NGN1, Q8NGN2, Q8NGR1, Q8NGR2, Q8NGR6, Q8NGT2, Q8NGW1, Q8NGW6, Q8NGZ2, Q8NGZ5, Q8NH06, Q8NH07
Diamond homologs: A6NDH6, A6NET4, A6NHG9, A6NKK0, A6NL26, A6NMS3, O95221, P0C626, P0C628, P0C7N1, P0C7N5, P0DMU2, P0DN80, P34985, P37068, P37070, P37071, P37072, Q13606, Q15617, Q15620, Q60880, Q60882, Q60884, Q60886, Q60893, Q60894, Q6UXT6, Q7TS48, Q8N127, Q8N146, Q8N162, Q8NG75, Q8NG78, Q8NGC0, Q8NGF4, Q8NGF7, Q8NGG0, Q8NGG1, Q8NGG2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 150820 | GRCh38/hg38 11q24.1-25(chr11:121689052-135075271)x1 | Pathogenic |
SpliceAI
231 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:124265038:T:TA | donor_gain | 0.9600 |
| 11:124265039:A:AA | donor_gain | 0.9600 |
| 11:124265029:GAATC:G | donor_gain | 0.8000 |
| 11:124265036:T:G | donor_gain | 0.6800 |
| 11:124265344:A:AG | donor_gain | 0.6400 |
| 11:124264988:G:GT | donor_gain | 0.6300 |
| 11:124265029:G:T | donor_gain | 0.6200 |
| 11:124264958:GAC:G | donor_gain | 0.5800 |
| 11:124264998:C:G | donor_gain | 0.5800 |
| 11:124265040:G:GG | donor_gain | 0.5800 |
| 11:124264960:C:CG | donor_gain | 0.5600 |
| 11:124264866:GAGAA:G | donor_gain | 0.5500 |
| 11:124265033:C:CG | donor_gain | 0.5400 |
| 11:124265697:GCATT:G | acceptor_gain | 0.5400 |
| 11:124264986:GAGAA:G | donor_gain | 0.5300 |
| 11:124264960:C:G | donor_gain | 0.5100 |
| 11:124265688:G:A | acceptor_gain | 0.5000 |
| 11:124264956:GTGAC:G | donor_gain | 0.4900 |
| 11:124264957:TGACT:T | donor_gain | 0.4900 |
| 11:124265033:C:G | donor_gain | 0.4900 |
| 11:124265104:C:G | donor_gain | 0.4800 |
| 11:124265601:A:AG | acceptor_gain | 0.4800 |
| 11:124265602:G:GG | acceptor_gain | 0.4800 |
| 11:124264958:GACTA:G | donor_gain | 0.4700 |
| 11:124264959:ACTAA:A | donor_gain | 0.4700 |
| 11:124265697:GC:G | acceptor_gain | 0.4700 |
| 11:124265107:T:G | donor_gain | 0.4600 |
| 11:124265559:CCCAG:C | acceptor_gain | 0.4600 |
| 11:124265560:CCAGC:C | acceptor_gain | 0.4600 |
| 11:124265561:CAGCC:C | acceptor_gain | 0.4600 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000135627 (11:124261045 G>A,T), RS1000293379 (11:124255371 T>A), RS1000324015 (11:124255709 C>CT), RS1000416941 (11:124260170 C>T), RS1000438776 (11:124255961 T>C), RS1000681835 (11:124261674 G>A,C), RS1001097405 (11:124266248 GT>G,GTT), RS1001699599 (11:124258942 A>G), RS1002082363 (11:124256927 A>G), RS1002433128 (11:124257367 A>G), RS1003445747 (11:124262112 G>T), RS1003478935 (11:124262405 A>C), RS1003529145 (11:124261768 A>G), RS1003701024 (11:124255748 A>G), RS1003978824 (11:124257413 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Lipopolysaccharides | increases expression, affects cotreatment, affects response to substance | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.